| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0004129 | Cytochrome-c oxidase activity | Decreases phenotype | PMID:28082109 |
| GO:0005975 | Carbohydrate metabolic process | Affects phenotype | PMID:34648870 |
| GO:0006096 | Glycolytic process | Affects phenotype | PMID:34648870 |
| GO:0006099 | Tricarboxylic acid cycle | Affects phenotype | PMID:34648870 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:29038090; PMID:30990016; PMID:30990016 |
| GO:0006338 | Chromatin remodeling | Increases phenotype | PMID:29038090 |
| GO:0006631 | Fatty acid metabolic process | Affects phenotype | PMID:34648870 |
| GO:0006687 | Glycosphingolipid metabolic process | Affects phenotype | PMID:34648870 |
| GO:0008137 | Nadh dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:28082109 |
| GO:0008177 | Succinate dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:28082109 |
| GO:0008207 | C21-steroid hormone metabolic process | Affects phenotype | PMID:34648870 |
| GO:0008652 | Amino acid biosynthetic process | Affects phenotype | PMID:34648870 |
| GO:0016125 | Sterol metabolic process | Affects phenotype | PMID:34648870 |
| GO:0019858 | Cytosine metabolic process | Affects phenotype | PMID:34648870 |
| GO:0019860 | Uracil metabolic process | Affects phenotype | PMID:34648870 |
| GO:0034773 | Histone h4-k20 trimethylation | Increases phenotype | PMID:25237060; PMID:30552462; PMID:30552462; PMID:30990016 |
| GO:0036124 | Histone h3-k9 trimethylation | Increases phenotype | PMID:30552462 |
| GO:0070085 | Glycosylation | Affects phenotype | PMID:34648870 |
| GO:0097043 | Histone h3-k56 acetylation | Decreases phenotype | PMID:25237060 |
| GO:0098532 | Histone h3-k27 trimethylation | Increases phenotype | PMID:30552462 |
| GO:1900113 | Negative regulation of histone h3-k9 trimethylation | Increases phenotype | PMID:30990016 |
| GO:1900114 | Positive regulation of histone h3-k9 trimethylation | Increases phenotype | PMID:25237060 |
| GO:1901535 | Regulation of dna demethylation | Affects phenotype | PMID:25237060 |
| GO:1901675 | Negative regulation of histone h3-k27 acetylation | Increases phenotype | PMID:30990016 |
| GO:1901676 | Positive regulation of histone h3-k27 acetylation | Increases phenotype | PMID:25237060 |
| GO:1902466 | Positive regulation of histone h3-k27 trimethylation | Increases phenotype | PMID:25237060 |
| GO:2000619 | Negative regulation of histone h4-k16 acetylation | Increases phenotype | PMID:25237060 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.